Feed VVOS
VV

Vivos Therapeutics, Inc.

VVOS · NASDAQ

$0.16 -4.13% (-$0.01)
1M -41.04%
Market Cap $2.22M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9
Valuation
100 /100
Cheap
P/S 0.11x
PEG N/A
P/E N/A
Growth
34 /100
Stable
Rev. growth 2.87%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak
Op. margin 107.92%
Gross margin 59.72%
FCF margin 81.88%
Quality
15 /100
Poor
Asset turnover 0.87x
ROIC 182.30%
ROA 105.97%
Debt
0 /100
High
Int. coverage -22.30x
Current ratio 0.21x
Debt/Assets N/A
Stability
38 /100
Moderate
EPS volatility 37.24%
Beta 6.00x
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o VVOS
Online

O podjetju

Vivos Therapeutics, Inc. (VVOS) is a company specializing in the treatment of sleep and breathing disorders, particularly obstructive sleep apnea. The company develops and commercializes therapeutic devices and solutions that assist patients with breathing difficulties during sleep. Vivos Therapeutics aims to improve sleep quality and patient health by focusing on strengthening the upper airway and enhancing ventilation. The company plays a pivotal role in the field of sleep medicine and respiratory disorders. Shares of Vivos Therapeutics, Inc. (VVOS) can be an interesting choice for investors tracking the healthcare sector and innovations in the treatment of sleep disorders.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

R. Kirk Huntsman

Employees

268

Headquarters

Littleton

Prihajajoči dogodki

18 NOV.

Earnings

Upcoming earnings report

57d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.